News in brief
Psychiatric drug development and an award for our Incubator: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
Stories tagged with 'Cancer'
B Cell Development
Ikaros and NuRD: A crucial partnership
New work has shown how a protein important in the development of B cells can repress target genes and regulate cell growth in leukaemia cells.
Cancer immune responses
New study paves way for immunotherapies tailored for childhood cancers
New research shows how children’s immune systems react differently to cancer than adult immune systems.
Zombie cell elimination
Inhibiting SMARCA4 powers the immune system to kill ‘zombie’ cancer cells
Scientists have developed a potential new approach for treating ovarian cancer by inhibiting a protein called SMARCA4.
Stopping cancer regrowth
Blocking the cell cycle inhibitor p21 prevents regrowth in lung cancer cells
Blocking the activity of a protein called p21 stops lung cancer cells entering a ‘sleep-like’ state that allows them to survive chemotherapy.
Unlocking Protein Secrets
UK Researchers Awarded £6.4M Grant to Study Protein Dynamics and Cell Health
A scientific breakthrough could be on the horizon as a UK researchers embark on a project to study protein S-acylation – a critical cellular process.
Improving ADCs
Imperial spinout Siftr Bio aims to improve precision of ADC cancer drugs
A new Imperial spinout aims to improve the performance of an emerging class of cancer treatments known as antibody-drug conjugates or ADCs.
Cutting-edge imaging
Ministers unveil new scanner to speed up diagnosis and treatment of disease
A new medical scanner which can help speed up the diagnosis and treatment of cancers and heart conditions has been unveiled in London.
Medtech funding boost
Cancer breath test and AI doctor funded through UK med-tech push
Two Imperial-led projects aimed at improving cancer diagnosis have been funded as part of a UK government drive to improve cancer care.
DRUG COULD BOOST CHEMO
Drug could boost chemotherapy to treat aggressive brain tumours
Imperial researchers have discovered a drug which could boost the effectiveness of chemotherapy to treat aggressive brain tumours in adults.
